Joining a clinical trial for cervical cancer opens the door to new treatments that could have life-changing effects.

HPV infection is most commonly associated with cervical cancer, since roughly 99 per cent of all cervical cancer cases are connected to HPV. Nonetheless, experts warn that HPV is a virus that affects ...

The Union health ministry plans to introduce the HPV vaccine under the national immunisation programme, aiming to prevent ...

A scientist from Oaxaca in Mexico has made a breakthrough in medicine by completely eliminating the Human Papillomavirus (HPV ...

A new University of Kentucky Markey Cancer Center study provides important insights for future clinical trials in treating ...

For the first time, Cuba is gearing up to integrate the human papillomavirus (HPV) vaccine into its National Immunization ...

HPV is responsible for more than 95% of cervical cancer cases in South Africa. If a high-risk HPV infection persists, it can ...

Genital human papillomavirus is the most common sexually transmitted infection in the United States and is thought to be ...

Researchers have demonstrated that self-sampling is just as effective as speculum-based testing for HPV detection.

This innovative approach will identify women with precancer and cancer in a single non-invasive test, having the potential to ...